Gadalquiver, John .

HRN: 21-47-96  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2022
METRONIDAZOLE 500MG (TAB)
06/27/2022
07/03/2022
PO
500mg
TID
AGE
Waiting Final Action 

Indication:  Empirical De-escalation    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: